• ̍̍ CSE: BRAX
  • ̍̍ OTC: BRAXF
  • ̍̍ FWB: 4960

Executive

Management Team.

Dr. Roger S. McIntyre

Chairman and Chief Executive Officer

Dr. Roger McIntyre is the chairman and chief executive officer of Braxia Scientific. Dr. McIntyre is the world’s top-ranked depression researcher and has almost 25 years of providing care and conducting research, along with drug discovery and development, for persons with depression and related disorders. He is currently also a professor of psychiatry and pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto, Canada.

Dr. Roger S. McIntyre
Stephen Brooks

Chief Financial Officer

Stephen Brooks is the chief financial officer of Braxia Scientific. Mr. Brooks is a seasoned finance professional with more than 25 years of experience across a range of industries, including telecommunications, sports, entertainment, media and retail. Mr. Brooks has spent ten years in public practice in Canada, the United States and United Kingdom, where his clients included a range of both public and private enterprises.

Stephen Brooks
Kevin Kratiuk

Vice President, Operations, Braxia Health Clinics

Kevin Kratiuk has been the Vice-President of Operations since July 2018. He obtained his Doctor of Pharmacy degree from Poznan University of Medical Sciences in 2014. Alongside CRTCE, Kevin also founded KJK Health, which consists of a family practice clinic alongside KJK Pharmacy. In addition, he has been providing medical education consults since 2010 to over 1,000 Canadian medical students studying abroad.

Kevin Kratiuk
Jason Wolkove

Chief Information Officer, Braxia Scientific

Braxia’s new Chief Information Officer, Jason Wolkove, is a seasoned technology executive bringing more than 20 years of experience growing complex technical product, sales and service teams and building SaaS software systems. Jason also brings deep expertise in both revenue cycle, data management and mining, and a proven ability to manage product development.

Jason Wolkove
Daniel Herrera

VP, R&D and Growth, Braxia Scientific

As Vice President, Research & Development and Growth, Daniel Herrera brings extensive experience in the life sciences industry including more than 15 years of senior-level experience in the pharmaceutical industry serving in various commercial and strategic roles at Eli Lilly and Company.

Daniel Herrera

Dr. Roger S. McIntyre

Chairman and Chief Executive Officer

Stephen Brooks

Chief Financial Officer

Peter Rizakos

Chief Legal Officer

Josh Rosenblat

Chief Medical & Scientific Officer & Board Member

Kevin Kratiuk

Vice President, Operations, Braxia Health Clinics

Jason Wolkove

Chief Information Officer, Braxia Scientific

Daniel Herrera

VP, R&D and Growth, Braxia Scientific